2021
DOI: 10.1016/j.ajo.2020.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Factors Associated With Favorable Laser Trabeculoplasty Response: IRIS Registry Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(22 citation statements)
references
References 61 publications
1
21
0
Order By: Relevance
“…The main reasons of exclusion were: no pre-LTP IOP recorded (34.6%), no baseline visual acuity (24.6%), no laterality specified (16.6%), and no sufficient IOP measurements for baseline (12.0%). There were 117,477 eyes categorized as “response-unknown” (excluded from present analysis) and 166,332 categorized as “nonresponders” (excluded form present analysis) and 97,148 (36.9%) were categorized as “responders.” 18 From the responder cohort, we included only the first treated eye (if both eyes were treated on different dates) or a randomly selected eye (if both eyes treated on the same date), as well as all unilaterally treated eyes, which resulted in the 79,332 patients/eyes included in the present analysis.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The main reasons of exclusion were: no pre-LTP IOP recorded (34.6%), no baseline visual acuity (24.6%), no laterality specified (16.6%), and no sufficient IOP measurements for baseline (12.0%). There were 117,477 eyes categorized as “response-unknown” (excluded from present analysis) and 166,332 categorized as “nonresponders” (excluded form present analysis) and 97,148 (36.9%) were categorized as “responders.” 18 From the responder cohort, we included only the first treated eye (if both eyes were treated on different dates) or a randomly selected eye (if both eyes treated on the same date), as well as all unilaterally treated eyes, which resulted in the 79,332 patients/eyes included in the present analysis.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, our survival analysis included only patients who had initially responded with adequate IOP reduction, such that the “nonresponders” that were excluded from our study would have been counted as “failures” by prior studies. 18 Furthermore, since the goal of our study was to assess the longevity of the LTP treatment effect, rather than the ability of LTP to stave off the addition of medications (which can occur despite a 20% or more IOP reduction from LTP), the addition of IOP-lowering medications after LTP treatment was a censoring rather than a failure event. This strategy perhaps better reflects the therapeutic effect of LTP in the context of medication confounders, although it limits the prognostic value of LTP in delaying additional IOP-lowering medication and/or procedures.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations